Philip Morris International Inc. (SWX:PMI)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 235.14B +8.7% |
| Revenue (ttm) | 34.38B +8.9% |
| Net Income | 8.76B +32.1% |
| EPS | 5.62 +31.8% |
| Shares Out | n/a |
| PE Ratio | 26.84 |
| Forward PE | 21.69 |
| Dividend | 4.62 (3.12%) |
| Ex-Dividend Date | Jun 25, 2026 |
| Volume | 46 |
| Open | 169.00 |
| Previous Close | 169.00 |
| Day's Range | 148.00 - 169.00 |
| 52-Week Range | 117.00 - 169.00 |
| Beta | 0.60 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 21, 2026 |
About SWX:PMI
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut. [Read more]
Financial Performance
In 2025, SWX:PMI's revenue was $40.65 billion, an increase of 7.31% compared to the previous year's $37.88 billion. Earnings were $11.32 billion, an increase of 60.88%.
Financial numbers in USD Financial StatementsNews
Altria announces arrangement with Philip Morris to enhance efficiency
Altria Group (MO) announced that Philip Morris USA has entered into a contract manufacturing arrangement with non-U.S. affiliates of Philip Morris International (PM) that is intended to enhance the ef...
Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency
RICHMOND, Va.--(BUSINESS WIRE)--Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency.
FDA authorizes 11 ZYN ULTRA products following scientific review
Philip Morris (PM) International announced that the U.S. Food and Drug Administration issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ...
Philip Morris gets FDA nod for 11 new nicotine pouches
The U.S. Food and Drug Administration said on Friday it had authorized 11 nicotine pouch products recently launched by Philip Morris , citing lower levels of harmful constituents compared with other...
FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI's U.S. affiliate, Swe...
Can nicotine pouches drive Big Tobacco's future beyond cigarettes?
Fast-growing nicotine pouches have emerged as one of Big Tobacco's most important bets on a future beyond cigarettes, offering rapid growth, attractive margins and, for now, lighter regulation than ma...
Philip Morris price target raised to $225 from $210 at Citi
Citi analyst Simon Hales raised the firm’s price target on Philip Morris (PM) to $225 from $210 and keeps a Buy rating on the shares.
Philip Morris price target raised to $225 from $205 at Barclays
Barclays analyst Pallav Mittal raised the firm’s price target on Philip Morris (PM) to $225 from $205 and keeps an Overweight rating on the shares. The firm views the negative…
Wolfe says buy these three quality stocks into post-earnings strength
July has dealt Wall Street a turbulent hand. US stocks have drifted lower this month, hampered by persistent geopolitical risks, rising crude oil prices, and mounting anxiety over rising AI capex.
ZYN growth EXPLODES as Philip Morris International expands US manufacturing
Philip Morris International U.S. CEO Stacey Kennedy discusses PMI's $1.2 billion investment in a new ZYN nicotine pouch manufacturing plant in Aurora, Colo., on 'The Claman Countdown.
Philip Morris Stock (PM) Lights Up as it Doubles Investment in New Smoke-Free Factory to $1.2B
Shares in tobacco company Philip Morris International ($PM) lit up today after it ramped up investment in a new manufacturing plant to meet rising demand for smoke-free nicotine-pouch products. Doubli...
Philip Morris Opens $1.2 Billion Manufacturing Campus to Grow Zyn Brand
Philip Morris International opened a $1.2 billion manufacturing campus in Colorado, part of the tobacco company's efforts to expand its Zyn portfolio and meet rising demand for nicotine pouches.
Philip Morris doubles Colorado campus investment to $1.2 billion
Philip Morris International said on Monday it had doubled its planned investment in its Colorado manufacturing campus to about $1.2 billion through 2028, as it expands production capacity for the Zy...
Philip Morris opens $1.2B Aurora campus
Philip Morris (PM) International’s U.S. businesses “celebrated” the opening of its Aurora, Colorado manufacturing campus, an investment representing total capital expenditures of $1.2B from 2024-2028....
PMI U.S. Opens $1.2 Billion Aurora Campus, Strengthening U.S. Manufacturing and Export Capabilities
STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc.'s (PMI) (NYSE: PM) U.S. businesses (PMI U.S.) today celebrated the opening of its Aurora, Colorado manufacturing campus, a landmark inve...
Philip Morris price target raised to $221 from $216 at BTIG
BTIG raised the firm’s price target on Philip Morris (PM) to $221 from $216 and keeps a Buy rating on the shares after its Q2 earnings beat. The firm is…
Philip Morris price target raised to $205 from $195 at Stifel
Stifel raised the firm’s price target on Philip Morris (PM) to $205 from $195 and keeps a Buy rating on the shares. The firm says its higher target is supported…
Philip Morris price target raised to $215 from $200 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Philip Morris (PM) to $215 from $200 and keeps an Overweight rating on the shares. Following the company’s Q2 report, the firm…
Philip Morris International Earnings Call Transcript: Q2 2026
Q2 and H1 saw strong organic growth in revenue, operating income, and EPS, driven by smoke-free products and robust combustible performance. Guidance remains unchanged as increased U.S. investment is planned for H2, especially behind ZYN and IQOS ILUMA.
Philip Morris International Slides: Q2 2026
Philip Morris International has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 22, 2026.
Philip Morris International Earnings release: Q2 2026
Philip Morris International released its Q2 2026 earnings on July 22, 2026, summarizing the period's financial results.
Philip Morris International Quarterly report: Q2 2026
Philip Morris International has published its Q2 2026 quarterly earnings report on July 22, 2026.
Philip Morris Stock Falls After It Cuts Guidance, but There Is One Bright Spot
Philip Morris International reports better-than-expected second-quarter earnings but lowers full-year profit expectations.
Philip Morris Sales Boosted by Growth in International Business
Philip Morris International recorded higher revenue in the second quarter, boosted by growth in its international business and its Zyn portfolio in the U.S.
Philip Morris beats second-quarter sales estimates
Philip Morris beat Wall Street estimates for second-quarter sales on Wednesday, helped by strong demand for smoke-free products following recent regulatory approval for its Zyn nicotine pouche...